April 22 (Reuters) - Amneal Pharmaceuticals has agreed to acquire biopharma firm Kashiv BioSciences in a cash-and-stock deal worth up to $1.1 billion that will expand the drugmaker's biosimilars ...
Some researchers are delighted at an executive order to streamline investigations of psychedelics but also warn that caution ...
President Trump's executive order is giving psychedelic stocks a boost. These companies are leaders in the industry.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results